FDA NDC Directory · JSON-LD · Markdown

ENALAPRILAT

NDC 51662-1477 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerHF Acquisition Co LLC, DBA HealthFirst
Marketing categoryAbbreviated NDA (generic) · App ANDA078687
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsENALAPRILAT (1.25 mg/mL)
Marketing started20200201
Package count1

External sources

Source: openFDA. Public-domain (CC0).